Clinical trial
Chemoradiation for Locally Advanced and Low Rectal Cancers…
NCT00386828 · British Columbia Cancer Agency, Other · Completed
Key facts
| NCT number | NCT00386828 |
|---|---|
| Title | Chemoradiation for Locally Advanced and Low Rectal Cancers: Avastin-Capecitabine-Oxaliplatin-Radiation REctal Cancer Trial |
| Official title | Phase II Study of Chemoradiation for Locally Advanced and Low Rectal Cancers: Avastin-Capecitabine-Oxaliplatin-Radiation REctal Cancer Trial |
| Lead sponsor | British Columbia Cancer Agency, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Advanced Colorectal Cancer |
| Intervention type | Drug |
| Interventions | Bevacizumab: |
| Enrollment | 43 |
| Start date | Oct 1, 2006 |
| Primary completion | May 1, 2009 |
| Completion | May 1, 2009 |
| First posted | Oct 12, 2006 |
| Last update posted | Nov 25, 2010 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: